Follow Us

       


"Like" us on Facebook

Clinical Trials

Disease or Condition
Cancer - Breast Cancer
Title
HER2 Positive, Metastatic with CNS progression after Trastuzumab
Description
Phase 1b/2 single-arm trial evaluating the combination of lapatinib, everolimus and capecitabine for the treatment of patients with HER2-positive metastatic breast cancer with CNS progression after trastuzumab.

Taguchi/TRIO B-09
IRB Number
NCT01783756
Inclusion/Notes

For more information, please click here: http://www.clinicaltrials.gov/ct2/show/NCT01783756?term=NCT01783756&rank=1

Status
Open to Enrollment
Principal Investigator
Julie Taguchi, MD
Contact Email
research@ccsb.org
Phone
(805) 898-2117

This is the fat footer - edit page 906 to add content.